Global (United States, European Union and China) Age-related Macular Degeneration Market Research Report 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Age-related Macular Degeneration Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Age-related Macular Degeneration Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Wet AMD
  • 1.4.3 Dry AMD
• 1.5 Market by Application
  • 1.5.1 Global Age-related Macular Degeneration Market Share by Application: 2020 VS 2026
  • 1.5.2 Drugstore
  • 1.5.3 Hospital
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Age-related Macular Degeneration Market Perspective (2015-2026)
• 2.2 Age-related Macular Degeneration Growth Trends by Regions
  • 2.2.1 Age-related Macular Degeneration Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Age-related Macular Degeneration Historic Market Share by Regions (2015-2020)
  • 2.2.3 Age-related Macular Degeneration Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Age-related Macular Degeneration Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Age-related Macular Degeneration Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Age-related Macular Degeneration Players by Market Size
  • 3.1.1 Global Top Age-related Macular Degeneration Players by Revenue (2015-2020)
  • 3.1.2 Global Age-related Macular Degeneration Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Age-related Macular Degeneration Market Concentration Ratio
  • 3.2.1 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Revenue in 2019
• 3.3 Age-related Macular Degeneration Key Players Head office and Area Served
• 3.4 Key Players Age-related Macular Degeneration Product Solution and Service
• 3.5 Date of Enter into Age-related Macular Degeneration Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Age-related Macular Degeneration Historic Market Size by Type (2015-2020)
• 4.2 Global Age-related Macular Degeneration Forecasted Market Size by Type (2021-2026)

5 Age-related Macular Degeneration Breakdown Data by Application (2015-2026)

• 5.1 Global Age-related Macular Degeneration Market Size by Application (2015-2020)
• 5.2 Global Age-related Macular Degeneration Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Age-related Macular Degeneration Market Size (2015-2020)
• 6.2 Age-related Macular Degeneration Key Players in North America (2019-2020)
• 6.3 North America Age-related Macular Degeneration Market Size by Type (2015-2020)
• 6.4 North America Age-related Macular Degeneration Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Age-related Macular Degeneration Market Size (2015-2020)
• 7.2 Age-related Macular Degeneration Key Players in Europe (2019-2020)
• 7.3 Europe Age-related Macular Degeneration Market Size by Type (2015-2020)
• 7.4 Europe Age-related Macular Degeneration Market Size by Application (2015-2020)

8 China

• 8.1 China Age-related Macular Degeneration Market Size (2015-2020)
• 8.2 Age-related Macular Degeneration Key Players in China (2019-2020)
• 8.3 China Age-related Macular Degeneration Market Size by Type (2015-2020)
• 8.4 China Age-related Macular Degeneration Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Age-related Macular Degeneration Market Size (2015-2020)
• 9.2 Age-related Macular Degeneration Key Players in Japan (2019-2020)
• 9.3 Japan Age-related Macular Degeneration Market Size by Type (2015-2020)
• 9.4 Japan Age-related Macular Degeneration Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Age-related Macular Degeneration Market Size (2015-2020)
• 10.2 Age-related Macular Degeneration Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Age-related Macular Degeneration Market Size by Type (2015-2020)
• 10.4 Southeast Asia Age-related Macular Degeneration Market Size by Application (2015-2020)

11 India

• 11.1 India Age-related Macular Degeneration Market Size (2015-2020)
• 11.2 Age-related Macular Degeneration Key Players in India (2019-2020)
• 11.3 India Age-related Macular Degeneration Market Size by Type (2015-2020)
• 11.4 India Age-related Macular Degeneration Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Age-related Macular Degeneration Market Size (2015-2020)
• 12.2 Age-related Macular Degeneration Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Age-related Macular Degeneration Market Size by Type (2015-2020)
• 12.4 Central & South America Age-related Macular Degeneration Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Bayer HealthCare
  • 13.1.1 Bayer HealthCare Company Details
  • 13.1.2 Bayer HealthCare Business Overview and Its Total Revenue
  • 13.1.3 Bayer HealthCare Age-related Macular Degeneration Introduction
  • 13.1.4 Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2015-2020))
  • 13.1.5 Bayer HealthCare Recent Development
• 13.2 F. Hoffmann-La Roche
  • 13.2.1 F. Hoffmann-La Roche Company Details
  • 13.2.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  • 13.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Introduction
  • 13.2.4 F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 13.2.5 F. Hoffmann-La Roche Recent Development
• 13.3 Novartis
  • 13.3.1 Novartis Company Details
  • 13.3.2 Novartis Business Overview and Its Total Revenue
  • 13.3.3 Novartis Age-related Macular Degeneration Introduction
  • 13.3.4 Novartis Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 13.3.5 Novartis Recent Development
• 13.4 Regeneron Pharmaceuticals
  • 13.4.1 Regeneron Pharmaceuticals Company Details
  • 13.4.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
  • 13.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Introduction
  • 13.4.4 Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 13.4.5 Regeneron Pharmaceuticals Recent Development
• 13.5 Alcon
  • 13.5.1 Alcon Company Details
  • 13.5.2 Alcon Business Overview and Its Total Revenue
  • 13.5.3 Alcon Age-related Macular Degeneration Introduction
  • 13.5.4 Alcon Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 13.5.5 Alcon Recent Development
• 13.6 Allergan
  • 13.6.1 Allergan Company Details
  • 13.6.2 Allergan Business Overview and Its Total Revenue
  • 13.6.3 Allergan Age-related Macular Degeneration Introduction
  • 13.6.4 Allergan Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 13.6.5 Allergan Recent Development
• 13.7 Avalanche
  • 13.7.1 Avalanche Company Details
  • 13.7.2 Avalanche Business Overview and Its Total Revenue
  • 13.7.3 Avalanche Age-related Macular Degeneration Introduction
  • 13.7.4 Avalanche Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 13.7.5 Avalanche Recent Development
• 13.8 Bausch+Lomb
  • 13.8.1 Bausch+Lomb Company Details
  • 13.8.2 Bausch+Lomb Business Overview and Its Total Revenue
  • 13.8.3 Bausch+Lomb Age-related Macular Degeneration Introduction
  • 13.8.4 Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 13.8.5 Bausch+Lomb Recent Development
• 13.9 Gilead Sciences
  • 13.9.1 Gilead Sciences Company Details
  • 13.9.2 Gilead Sciences Business Overview and Its Total Revenue
  • 13.9.3 Gilead Sciences Age-related Macular Degeneration Introduction
  • 13.9.4 Gilead Sciences Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 13.9.5 Gilead Sciences Recent Development
• 13.10 Iconic Therapeutics
  • 13.10.1 Iconic Therapeutics Company Details
  • 13.10.2 Iconic Therapeutics Business Overview and Its Total Revenue
  • 13.10.3 Iconic Therapeutics Age-related Macular Degeneration Introduction
  • 13.10.4 Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 13.10.5 Iconic Therapeutics Recent Development
• 13.11 Neurotech Pharmaceuticals
  • 10.11.1 Neurotech Pharmaceuticals Company Details
  • 10.11.2 Neurotech Pharmaceuticals Business Overview and Its Total Revenue
  • 10.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Introduction
  • 10.11.4 Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 10.11.5 Neurotech Pharmaceuticals Recent Development
• 13.12 Ohr Pharmaceutical
  • 10.12.1 Ohr Pharmaceutical Company Details
  • 10.12.2 Ohr Pharmaceutical Business Overview and Its Total Revenue
  • 10.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Introduction
  • 10.12.4 Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2015-2020)
  • 10.12.5 Ohr Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer